Malaysia is experiencing a significant surge in dengue cases, resulting in dozens of deaths. Medical experts attribute the low uptake of available vaccines not to hesitancy, but to the high cost of the two-dose regimen, which can range from $104 to $124 USD. This expense makes the dengue vaccine less appealing compared to more affordable alternatives like the flu vaccine, especially for travelers. Furthermore, the vaccine is not suitable for certain groups, including pregnant women, breastfeeding mothers, and immunocompromised individuals, and is recommended only for those aged four to 60. AI
RANK_REASON Public health crisis with significant mortality and discussion of contributing factors like cost and vaccine limitations. [lever_c_demoted from significant: ic=1 ai=0.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
